Literature DB >> 27606448

Merck stakes out 'irritable' neuron territory with $1.25 billion.

Cormac Sheridan.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27606448     DOI： 10.1038/nbt0916-900

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Authors:  Rayid Abdulqawi; Rachel Dockry; Kimberley Holt; Gary Layton; Bruce G McCarthy; Anthony P Ford; Jaclyn A Smith
Journal:  Lancet       Date:  2014-11-25       Impact factor: 79.321

2.  Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.

Authors:  Anatoly Shcherbatko; Davide Foletti; Kris Poulsen; Pavel Strop; Guoyun Zhu; Adela Hasa-Moreno; Jody Melton Witt; Carole Loo; Stellanie Krimm; Ariel Pios; Jessica Yu; Colleen Brown; John K Lee; Robert Stroud; Arvind Rajpal; David Shelton
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.